Edition:
United States

Dentsply Sirona Inc (XRAY.OQ)

XRAY.OQ on NASDAQ Stock Exchange Global Select Market

44.68USD
3:28pm EDT
Change (% chg)

$-0.27 (-0.60%)
Prev Close
$44.95
Open
$45.00
Day's High
$45.22
Day's Low
$44.36
Volume
367,482
Avg. Vol
841,864
52-wk High
$68.97
52-wk Low
$41.65

Summary

Name Age Since Current Position

Eric Brandt

55 2017 Non-Executive Independent Chairman of the Board

Donald Casey

58 2018 Chief Executive Officer, Director

Nicholas Alexos

53 2017 Chief Financial Officer, Executive Vice President, Chief Administrative Officer

Maureen MacInnis

56 2016 Chief Human Resource Officer, Senior Vice President

Keith Ebling

47 2017 Executive Vice President, General Counsel, Secretary

Rainer Berthan

53 2016 Executive Vice President, Manufacturing and Supply Chain

Thomas Jetter

60 2016 Lead Independent Director

David Beecken

70 2016 Director

Betsy Holden

61 2018 Director

Arthur Kowaloff

70 2016 Director

Harry Kraemer

63 2016 Director

Leslie Varon

60 2018 Director

Michael Alfano

68 2001 Independent Director

Michael Coleman

73 1993 Independent Director

Willie Deese

62 2011 Independent Director

Francis Lunger

71 2005 Independent Director

Derek Leckow

VP, Investor Relations

Biographies

Name Description

Eric Brandt

Mr. Eric K. Brandt serves as Non-Executive Independent Chairman of the Board of the Company. Mr. Brandt has served as a Director on the Company’s Board of Directors since 2004. Mr. Brandt served as Executive Vice President and Chief Financial Officer of Broadcom Corporation, a Fortune 500 high-tech company from 2007-2016. From September 2005 until March 2007, he served as President and Chief Executive Officer at Avanir Pharmaceuticals. Beginning in 1999, he held various positions at Allergan, Inc., including Corporate Vice President and Chief Financial Officer until 2001, President of Consumer Eye Care from 2001 to 2002, and 2005 until his departure, Executive Vice President of Finance and Technical Operations and Chief Financial Officer. Prior to joining Allergan, he was Vice President and Partner at Boston Consulting Group (‘‘BCG’’), and a senior member of the BCG Health Care and Operations practices. Mr. Brandt served as a director of Vertex Pharmaceuticals, Inc. from 2002 to 2009 and as a director of Avanir Pharmaceuticals from 2005 to 2007. He serves on the Board of Directors for LAM Research Corporation as the Chair, Audit Committee. He also serves on the Board of Directors for Altaba Inc. (formerly Yahoo! Inc.) as Chair, Audit and Governance Committees and Board Chairman. Further, he serves on the Board of Directors for MC10, Inc., a private medical device manufacturer.

Donald Casey

Mr. Donald M. Casey has been appointed Chief Executive Officer, Director of the Company effective February 12, 2018. Mr. Casey has more than 30 years of global health care experience and an outstanding track record in identifying and commercializing medical innovations. He most recently served as Chief Executive Officer of the Medical segment of Cardinal Health, a leading manufacturer and provider of medical products and supply chain services to hospitals, laboratories, physician offices, surgery centers and other sites of care across the health care continuum. Under Don Casey's leadership as the CEO of the Medical segment, he repositioned the segment and delivered consistent revenue and operating income growth, meaningful margin expansion and helped position the segment for sustainable growth going forward. Prior to Cardinal Health, Mr. Casey served as Chief Executive Officer of the Gary and Mary West Wireless Health Institute, a non-profit research organization focused on lowering the cost of health care through novel technology solutions from 2010 to 2012. Previously, Mr. Casey served as worldwide chairman for Johnson & Johnson's comprehensive care group and a member of the company's executive committee, where he oversaw its cardiovascular, diagnostic, diabetes and vision care franchises around the world. Mr. Casey began his career with Johnson & Johnson in 1985, advancing into executive positions throughout the company's consumer, pharmaceutical and medical device franchises. Mr. Casey serves on the boards of AdvaMed and the James Foundation. Previously, he also served on the boards of Surgical Specialties (formerly AngioTech) and West Corp. He earned a bachelor's degree in finance and a master of business administration degree from the University of Notre Dame.

Nicholas Alexos

Mr. Nicholas W. Alexos is re designated as Chief Financial Officer, Executive Vice President, Chief Administrative Officer of the company effective November 10, 2017. He joins as EVP, Chief Administrative Officer, reporting directly to Mark Thierer, Interim Chief Executive Officer. In this role, he will lead Treasury, Information Technology, Business Development, Strategic Planning, and Investor Relations. Mr. Alexos was most recently with Madison Dearborn Partners LLC, a leading Chicago-based private equity firm which he co-founded. Prior to that, he was with First Chicago Venture Capital and the First National Bank of Chicago. He is a CPA and received his MBA from The University of Chicago Booth School of Business.

Maureen MacInnis

Ms. Maureen J. MacInnis serves as Senior Vice President and Chief Human Resources Officer of Dentsply Sirona. Formerly, Ms. MacInnis held the title of Vice President, Chief Human Resources Officer of DENTSPLY since April 2009. In this role, Ms. MacInnis helps drive growth through clear linkage between the business strategy and people strategies, talent management and succession processes, as well as compensation and benefits, employee relations, leadership development and training. Ms. MacInnis has over 30 years of experience in all aspects of Human Resources, particularly with expertise in organization design, acquisition, succession planning and communications. Prior to joining DENTSPLY, Ms. MacInnis held Human Resources executive positions at CIGNA and at Trane Corporation. Ms. MacInnis received an MBA from Lehigh University.

Keith Ebling

Mr. Keith J. Ebling is Executive Vice President, General Counsel, Secretary of the company. He comes to Dentsply Sirona from Express Scripts Holding Company, a $100 billion integrated pharmacy benefit management company. He served in a number of legal and leadership roles over his nearly 20 years with the company, most recently as Executive Vice President and General Counsel. Prior to that, Mr. Ebling was an associate with a private firm in St. Louis that he joined after graduating as valedictorian and magna cum laude from Saint Louis University School of Law. He also has his MBA from Washington University Olin School of Business.

Rainer Berthan

Mr. Rainer Berthan serves as the Executive Vice President, Manufacturing and Supply Chain at Dentsply Sirona. He is also Managing Director at the Dentsply Sirona Bensheim site. He leads the manufacturing and supply chain function globally. Formerly, Mr. Berthan held the position of Executive Vice President of Sirona since August 2012. Before joining Sirona, Mr. Berthan worked for five years in the MDAX-listed joint stock company Demag Cranes, where he was member of the Executive Committee of the company holding, as well as the Managing Director of the two subsidiaries Demag Cranes & Components and Gottwald Port Technology - both world leaders in their specific mechanical engineering fields. From 2004 to 2008, Mr. Berthan was the Managing Director of the Chinese subsidiary of Weidmüller, a German electrotechnology company. Between 2002 and 2004 he was a member of the board of New Tech Com Europe, a leading provider of mobile communications infrastructure. Prior to this, Mr. Berthan held various management positions at RWE and Daimler-Benz. Mr. Berthan has a degree in business administration from the Munich University of Applied Sciences.

Thomas Jetter

Mr. Thomas Jetter is Lead Director, Independent Director of the Company. Mr. Thomas Jetter currently serves as the Company’s Lead Director on its Board of Directors. Formerly, Mr. Jetter served as a Sirona Director from April 2010 through the Merger and Chairman of Sirona’s Board from February 20, 2013 through the Merger. Mr. Jetter also served as a member of the Nominating and Corporate Governance Committee and a member of the Finance Committee of Sirona’s Board of Directors. Mr. Jetter also serves as Chairman of the Board of Directors of HQ Capital, a privately held alternative asset management firm in Germany.

David Beecken

Mr. David K. Beecken is Director of the Company. Mr. Beecken currently serves as a Director on the Company’s Board of Directors. Formerly, Mr. Beecken served as a Sirona Director from June 2006 through the Merger and Chairman of the Audit Committee and member of the Finance Committee of Sirona’s Board of Directors. Mr. Beecken currently serves as a Partner of Beecken Petty O’Keefe & Company, which is the General Partner of Beecken Petty O’Keefe Funds I, II, III & IV investment limited partnerships focused exclusively on private equity investments in healthcare. Prior to co-founding Beecken Petty O’Keefe in April 1996, Mr. Beecken was Senior Managing Director of ABN AMRO Incorporated, a broker dealer, from February 1993 to March 1996. From 1989 to February 1993, Mr. Beecken was a Senior Vice President-Managing Director of First National Bank of Chicago. Mr. Beecken also serves on the Boards of Directors of Scrip Products Corporation and Paragon Medical, Inc. Mr. Beecken received a B.A. from the University of the South, an M.Sc. from the London School of Economics and an M.B.A. from the University of Chicago.

Betsy Holden

Ms. Betsy D. Holden has been appointed Director of the Company effective February 12, 2018. Betsy D. Holden is a senior advisor to McKinsey & Company, working with clients across industries on strategy, marketing, innovation, and board effectiveness initiatives. Ms. Holden was formerly Co-CEO of Kraft Foods and CEO of Kraft Foods North America. At the time, Kraft Foods was the largest food company in North America and the second largest in the world. In addition to her CEO role at Kraft, Ms. Holden also held the positions of president, Global Marketing and Category Development; executive vice president with responsibility for Operations, IT, Procurement, R&D, and Consumer Insights and Communications; president of the Kraft Cheese Division; president of the Pizza Division; plus multiple line brand management assignments. Ms. Holden introduced new products that generated over $2 billion in revenue and under her leadership Kraft received numerous marketing, new product, and 'best places to work' accolades. Ms. Holden serves on the Board of Diageo PLC, Time Inc. and The Western Union Company. Previously, she also served on the Boards of Catamaran Corp., Tribune Co., Kraft Foods and Tupperware Brands. Ms. Holden graduated Summa Cum Laude and Phi Beta Kappa with a BA from Duke University and received a Masters of management in marketing and finance from Northwestern University's Kellogg School of Management. She was named to Fortune's Most Powerful Women's list multiple times.

Arthur Kowaloff

Mr. Arthur D. Kowaloff is Director of the Company. Mr. Kowaloff currently serves as a Director on the Company’s Board of Directors. Formerly, Mr. Kowaloff served as a Sirona Director from 2006 through the Merger and as a Director of Schick Technologies, Inc. (“Schick”) from 2004 to 2006. Mr. Kowaloff served as a member of the Audit Committee of Sirona’s Board of Directors from October 2004 through February 2016. Mr. Kowaloff served as a member of the Compensation Committee of Sirona’s Board of Directors from August 2011 through February 2016. From June 2006 through February 2016, he served on the Nominating and Corporate Governance Committee and, until October 2011, on the Finance Committee of Sirona’s Board of Directors. From October 2004 until June 2006, he served on the Compensation Committee of Sirona’s Board of Directors, and as Chairman of the Special Litigation Committee from November 2004 until June 2006. From 2014 to the present, Mr. Kowaloff has served as a director of United States Enrichment Corp, a wholly owned subsidiary of Centrus Energy. In 2014 and 2015, Mr. Kowaloff served as a director of Reichhold Chemicals, Inc. and from 2010 until 2012, he served as lead director of Metropolitan Health Networks, Inc. From 1998 to 2003, Mr. Kowaloff served as a Managing Director of BNY Capital Markets, Inc. From 1991 to 1998, he was Chief Operating Officer and Senior Managing Director of Patricof? & Company Capital Corporation. Prior to that, Mr. Kowaloff was an attorney at the New York City firm of Willkie Farr & Gallagher, where he served as Senior Partner and Executive Committee Member and specialized in corporate and securities law and mergers and acquisitions. Mr. Kowaloff is currently a Trustee of Carleton College, the President and a Director of the PBP Foundation of New York, and a Director and Chairman of the Audit and Compliance and Compensation Committees of the Greater Hudson Valley Health System. Mr. Kowaloff received a B.A. from Carleton College and holds a Juris Doctor degree from Yale Law S

Harry Kraemer

Mr. Harry M. Jansen Kraemer, Jr. is Director of the Company. Mr. Kraemer currently serves as a Director on the Company’s Board of Directors. Formerly, Mr. Kraemer served as a Sirona Director as well as Chairman of the Nominating and Corporate Governance Committee and member of the Compensation Committee of Sirona’s Board of Directors from June 2006 through the Merger. Mr. Kraemer currently serves as an Executive Partner of Madison Dearborn Partners, LLC, a private equity investment firm based in Chicago that invests in management buyout and other private equity transactions across a broad spectrum of industries and serves as Clinical Professor of Management & Strategy at Northwestern University’s Kellogg School of Management. Mr. Kraemer was the Chairman, President and Chief Executive Officer of Baxter International Inc. until April 2004. Mr. Kraemer had been a Director of Baxter International since 1995, Chairman of the Board since January 1, 2000, President since 1997 and Chief Executive Officer since January 1, 1999. Mr. Kraemer is active in business, education and civic affairs. He serves on the board of directors of Leidos Corporation and as chairman of its Audit Committee. He also serves on the board of directors of VWR International, Inc. In addition, he serves on the board of trustees of Northwestern University, the Conference Board and NorthShore University HealthSystem. He is also a member of the Dean’s Advisory Board of Northwestern University’s Kellogg School of Management, the Commercial Club of Chicago and the Economics Club of Chicago. He is a past member of the Business Roundtable, the Business Council and the Healthcare Leadership Council. Mr. Kraemer received a B.A. from Lawrence University and an M.B.A. from the Kellogg School of Management at Northwestern University and is a certified public accountant.

Leslie Varon

Ms. Leslie F. Varon has been appointed Director of the Company. Ms. Varon has an extensive record of financial and business leadership in corporate financial management and investor relations. She has significant experience driving business transformation over 30 years at Xerox Corporation, including complex turnarounds, mergers and acquisitions, crisis management and the spinoff of a major business unit. During her career with Xerox, Ms. Varon has served in a variety of senior roles including as the company's Chief Financial Officer, corporate controller, vice president of finance for North America and head of investor relations and was responsible for all finance, treasury, investor relations, risk management, mergers and acquisitions, tax, audit, procurement and real estate operations at Xerox. Ms. Varon serves on the Board of Hamilton Lane Incorporated. Ms. Varon holds a Bachelor of Arts degree from Binghamton University and a Master's degree in Business Administration with concentrations in finance and marketing from Virginia Polytechnic Institute.

Michael Alfano

Dr. Michael C. Alfano, Ph.D., is an Independent Director of the Company. Dr. Alfano currently serves as a Director on the Company’s Board of Directors. Formerly, Dr. Alfano served as a DENTSPLY Director from 2001 through the Merger. Dr. Alfano is Executive Vice President Emeritus, and Professor and Dean Emeritus at New York University (‘‘NYU’’). Dr. Alfano served as Dean of the College of Dentistry from 1998 to 2006 and as Executive Vice-President of NYU from 2006 to 2013. Beginning in 1982 until 1998 he held a number of positions with Block Drug Company, including Senior Vice President for Research & Technology and President of Block Professional Dental Products Company. He served on the Board of Directors of Block Drug Company, Inc. from 1988 to 1998. Dr. Alfano has served as a member of, or consultant to, various public health organizations, including the National Institutes of Health, the Editorial Board of the American Journal of Dentistry, the Consumer Healthcare Product Association and as the industry representative to the Non-Prescription Drugs Advisory Committee of the FDA from 2001 to 2005. He was a founding director of the Friends of the National Institute for Dental and Craniofacial Research, and he is a founding director of the not-for-profit Santa Fe Group. He was also a Trustee of the New York State Dental Foundation until 2006. From 2010-2015 he served as a director of the not-for-profit Delta Dental of New York Insurance Company. He also served as a Director of the YMCA of Greater New York, the largest YMCA system in the country, from 2010 to 2014. He has received numerous honors, research grants and awards, and currently serves as Senior Consultant to the Academy for Academic Leadership, and President of the Santa Fe Group.

Michael Coleman

Mr. Michael J. Coleman is an Independent Director of the Company. Mr. Coleman currently serves as a Director on the Company’s Board of Directors. Formerly, Mr. Coleman served as a DENTSPLY Director from 1991 through the Merger. Mr. Coleman is the Chairman of the Board of Cool Media Company and a partner in CS&W Associates Media Management, both based in Cocoa Beach, Florida. He served as Chairman of Cape Publications in Melbourne, Florida until retiring from that position on January 1, 2007. He previously served as Publisher of FLORIDA TODAY and President of the Gannett Co., Inc., South Newspaper Group from 1991 to April 2006. He serves as a director of Ron Jon Surf Shops Worldwide and Florida Bank of Commerce, Orlando, Florida, and as a Trustee of the Freedom Forum, The Newseum and The Newseum Institute, all based in Washington, D.C. Prior to the merger of Dentsply International Inc. with Gendex on June 11, 1993, Mr. Coleman served as a director of Gendex.

Willie Deese

Mr. Willie A. Deese is an Independent Director of the Company. Mr. Deese currently serves as a Director on the Company’s Board of Directors. Formerly, Mr. Deese served as a DENTSPLY Director from 2011 through the Merger. Mr. Deese retired from Merck & Co., Inc. on June 1, 2016 after serving as Executive Vice President since 2008 and President of the Merck Manufacturing Division since 2005. He is also a member of Merck’s Executive Committee. Mr. Deese originally joined Merck in 2004 as the company’s Senior Vice President of Global Procurement. Mr. Deese currently serves on the Board of CDK Global as Chair, Compensation and Benefits Committee and as a member of the Audit Committee. He also serves as a Director for PSEG (Public Service Enterprise Group, Inc.) where he is a member of the Organization and Compensation Committee and the Corporate Governance Committee. Formerly, Mr. Deese served as a member of the Board of Trustees of North Carolina A&T State University from 2007 to 2015. In addition, Mr. Deese served as the Chair of the Board of Trustees of North Carolina A&T State University from 2011 to 2013. Previously, Mr. Deese served as Senior Vice President of Global Procurement and Logistics at GlaxoSmithKline and as Senior Vice President of Procurement at SmithKlineBeecham.

Francis Lunger

Mr. Francis J. Lunger is an Independent Director of the Company. Mr. Lunger currently serves as a Director on the Company’s Board of Directors. Formerly, Mr. Lunger served as a DENTSPLY Director from 2005 through the Merger. Mr. Lunger served on the Board of Millipore Corporation from 2001 until March 2005, including serving as Chairman from April 2002 until April 2004. Mr. Lunger joined Millipore in 1997 as Senior Vice President and Chief Financial Officer and held several executive management positions, which included serving as Executive Vice President and Chief Operating Officer from 2000 until 2001, and Chairman, President and Chief Executive Officer from August 2001 until January 2005. Prior to joining Millipore, Mr. Lunger held executive management positions at Oak Industries, Inc., Nashua Corporation, and Raychem Corporation. From June 2007 through July 2010, Mr. Lunger served as a director of NDS Surgical Imaging. From July 2009 to December 2012, Mr. Lunger was an Operating Partner with Linden LLC. Since April 2012, Mr. Lunger has been the Chairman of the Board of Directors of Sera Care Life Sciences Inc.

Derek Leckow